PMID: 16615663Apr 18, 2006Paper

Toxicoepidemiology in Zimbabwe: admissions resulting from exposure to paraffin (kerosene)

Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
Dexter TagwireyiC F Nhachi

Abstract

Paraffin (kerosene) ingestion is the most common form of childhood poisoning in most developing countries. Despite this, there is a paucity of toxicoepidemiological data which could potentially be used in measures to reduce preventable exposures. This article reports on the patterns of hospital admissions resulting from paraffin exposure in Zimbabwe. All cases of paraffin ingestion admitted to eight major referral hospitals in Zimbabwe from January 1998 to December 1999 (inclusive), were identified using ICD-9 codes and ward registers and relevant information recorded on a standard data collection sheet. There were a total of 327 admissions due to oral exposure to paraffin. This represented 11.8% of all the poisoning admissions to the eight study hospitals. Most exposures (300; 91.7%) occurred accidentally, with only 6.7% resulting from deliberate ingestion of the chemical. The median age on admission was 2 years (interquartile range [IQR] 1-2 yrs) with over 85% of cases in the 0-5 year age range and less than 10% above the age of 12 years. The median age on admission was much higher for deliberate self poisoning (23 yrs; IQR 19-26 yrs) compared to that for accidental poisoning (1.5 yrs; IQR 1-2 yrs). Accidental poisoning from ...Continue Reading

References

Aug 6, 1977·Lancet·J R SibertR H Jackson
Sep 1, 1992·Human & Experimental Toxicology·O M Kasilo, C F Nhachi
Jan 1, 1992·Annals of Tropical Paediatrics·H SinghH C Mehta
Jan 1, 1991·Annals of Tropical Paediatrics·A A DudinB A Libdeh
Feb 1, 1970·Postgraduate Medical Journal·L Nouri, K al-Rahim
Jul 2, 1983·British Medical Journal·G R LawsonR H Jackson
Mar 1, 1982·Annals of Tropical Paediatrics·M A St John
Feb 1, 1994·Human & Experimental Toxicology·C F Nhachi, O M Kasilo
Mar 1, 1997·Annals of Tropical Paediatrics·R P Reed, F M Conradie
May 20, 1998·Clinical and Experimental Pharmacology & Physiology·N A Buckley
Jan 30, 1999·Annals of Tropical Paediatrics·K SimmankA Tomkins
Oct 21, 2000·Curationis·T Mhlongo, K Peltzer
Mar 3, 2001·The New England Journal of Medicine·P E Marik
Mar 29, 2002·Journal of Applied Toxicology : JAT·D TagwireyiC F B Nhachi
May 7, 2002·Tropical Doctor·F Abu-Ekteish
Oct 1, 1964·Archives of Disease in Childhood·E A CACHIA, F F FENECH

❮ Previous
Next ❯

Citations

Jun 18, 2009·International Journal of Nursing Practice·Wananani Tshiamo
Jan 20, 2018·International Journal of Pediatrics·M B Kavinda Chandimal DayasiriChamilka Y Jayasinghe
Nov 25, 2016·Journal of Toxicology·Dexter TagwireyiMandy Maredza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
Dexter TagwireyiC F Nhachi
Tropical Medicine & International Health : TM & IH
T LangS Akech
Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
Dexter TagwireyiC F Nhachi
© 2022 Meta ULC. All rights reserved